Monday 25 Nov, 2024 02:12 PM
Site map | Locate Us | Login
   Dev Info Tech hits life high after board OKs stock split proposal    Sarda Energy spurts on emerging as preferred bidder by Chhattisgarh Govt    RBL Bank Ltd gains for third consecutive session    Indian Bank spurts 6.58%, up for third straight session    J B Chemicals & Pharmaceuticals Ltd up for third consecutive session    Torrent Pharmaceuticals Ltd spurts 1.59%, rises for third straight session    Hindalco Industries Ltd up for third consecutive session    Tata Steel Ltd gains for third straight session    ICICI Bank Ltd soars 2.34%, rises for third straight session    Divis Laboratories Ltd spurts 1.29%, gains for five straight sessions    Lupin Ltd gains for fifth session    BSE climbs on plans to expand F&O segment with 43 new stocks    Central Bank of India soars after RBI clears acquisition of stake in FGIICL, FGILICL    Uniparts India appoints Tanushree Bagrodia as whole time director & COO    SIS board OKs proposal to issue NCDs worth Rs 250 crore 
Saravan Stocks
       
Hot Pursuit
Scrips, which has significant changes during the market hours.
Bliss GVS Pharma soars after manufacturing units get GMP certificate from Romania medical authority
25-Nov-24   09:40 Hrs IST

In a regulatory filing made on Saturday, the company informed that its manufacturing facilities located at Aliyali Village and Vevoor Village in Palghar district of Maharashtra has received a Certificate of GMP (good manufacturing practice) Compliance from the National Agency for Medicines and Medical Devices of Romania (NAMMDR).

The compliance certificate has been granted following an EU GMP inspection that took place on 30th November and 1st December 2023 at the said facilities.

Bliss develops and manufactures pharmaceutical formulations mainly for sale in Africa. The company sells formulations in the form of suppositories, pessaries, capsules, tablets, and syrups. It manufactures more than 250 branded formulations in the anti-malarial, anti-fungal, anti-bacterial, anti-biotic, anti-inflammatory, contraceptive, and anti-diabetic segments. Bliss also contract-manufactures suppositories and pessaries for Sun Pharma and Mankind.

The company's consolidated net profit declined 42.66% to Rs 24.26 crore despite a 2.74% rise in net sales to Rs 217.68 crore in Q2 FY25 as compared with Q2 FY24.

Powered by Capital Market - Live News
   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com,  Mobile No: 7305522205
Investor Charter | Annual Return | Span Margin | Disclaimer | Feed Back | Privacy Policy | Policies & Procedures |DP Closure| |Rights & Obligations-English| Rights & Obligations-தமிழ் | Anti Money Laundering Policy | E-Voting | CSR | Voluntary Freezing / Blocking Hit Count : 37087620
Useful Links : NSE | BSE | MCX | NSDL | CDSL | SEBI | RBI | ATTENTION INVESTOR| SMART ODR
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 56990 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. SSPL WEALTH Pvt. Ltd